Sena Kim, PhD, Instructor in Medicine, WashU Medicine Division of Oncology, is a recipient of a St. Baldrick’s Foundation grant. The St. Baldrick’s Foundation, the largest charity funder of childhood cancer research grants, recently announced the newest round of research grants totaling $10 million.
The new grants demonstrate St. Baldrick’s ongoing commitment to funding the most promising childhood cancer research-supporting projects starting with early-stage clinical trials all the way through to advanced clinical trials.
I am deeply honored to receive the St. Baldrick’s Foundation Scholar Award, which will support efforts to make lifesaving hematopoietic stem cell transplants safer for patients with blood cancers. This award provides an exciting opportunity to build upon and expand my research in the emerging area of graft-versus-host disease and metabolism in allogeneic hematopoietic cell transplantation.
I am incredibly lucky and grateful to have such amazing mentors, Dr. Jaebok Choi and Dr. John DiPersio, and the loving support of my wonderful husband Kyungsoo and family who always believe in me to keep me moving forward.
– Sena Kim, PhD
About St. Baldrick’s Foundation
Every 2 minutes, a child somewhere in the world is diagnosed with cancer. In the U.S., 1 in 5 will not survive. The St. Baldrick’s Foundation, the largest charity funder of childhood cancer research grants, has awarded more than $368 million to researchers to Conquer Kids’ Cancer. When you give to St. Baldrick’s, you don’t just give to one hospital – you support every institution with the expertise to treat kids with cancer across the U.S. St. Baldrick’s ensures that children fighting cancer now — and those diagnosed in the future — will have access to the most cutting-edge treatment, by supporting every stage of research, from new ideas in the lab to the training of the next generation of researchers, to lifesaving clinical trials.
St. Baldrick’s has played a role in virtually every advancement in the field over the past 25 years and remains essential in advancing progress and fostering innovation in childhood cancer research.
